Gina Mejía-Abril

19PUBLICATIONS
27CO-AUTHORS
Haematological tumoursPharmacogenomicsGenome structure and regulationEpidemiological modellingMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 30, 2025
Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study.

Noelia Pérez-Gómez, Antonio Sanz-Solas, Beatriz Cuevas

|Feb 26, 2025
Impact of Genetic Variants on Pregabalin Pharmacokinetics and Safety.

Sofía Calleja, Andrea Rodríguez-López, Dolores Ochoa

|Jan 11, 2025
Effect of Genetic Variants on Rosuvastatin Pharmacokinetics in Healthy Volunteers: Involvement of ABCG2, SLCO1B1 and NAT2.

Eva González-Iglesias, Clara Méndez-Ponce, Dolores Ochoa

|Sep 28, 2024
An Investigational Study on the Role of CYP2D6, CYP3A4 and UGTs Genetic Variation on Fesoterodine Pharmacokinetics in Young Healthy Volunteers.

Andrea Rodríguez-Lopez, Dolores Ochoa, Paula Soria-Chacartegui

|Aug 29, 2024
Genetic Variation in CYP2D6, UGT1A4, SLC6A2 and SLCO1B1 Alters the Pharmacokinetics and Safety of Mirabegron.

Paula Soria-Chacartegui, Patricia Cendoya-Ramiro, Eva González-Iglesias

|Jan 23, 2024
Use of Exposure Data to Establish Causality in Drug-Adverse Event Relationships: An Example with Desvenlafaxine.

Andrea Rodríguez-Lopez, Gina Mejía-Abril, Pablo Zubiaur

Pageof 4

Frequent Collaborators

19 joint publications

Francisco Abad-Santos

15 joint publications

Pablo Zubiaur

10 joint publications

Gonzalo Villapalos-García

7 joint publications

Paula Soria-Chacartegui